Kontigo Care (KONT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Revenue grew 4.3% year-over-year to 7.4 MSEK, with stable income trends and improved cash flow compared to Q1 2025.
EBIT turned positive at 0.2 MSEK (3.3% margin) versus -0.6 MSEK (-7.9%) last year, reflecting cost efficiency and structural changes.
The company is debt-free with a strong cash position, enabling investments in growth without compromising financial discipline.
Product portfolio streamlined and transition to a capacity-based contract model underway, aiming for longer customer relationships and more stable recurring revenue.
Organizational restructuring supports international expansion, with Finland as a key growth market.
Financial highlights
Monthly Recurring Revenue (MRR) at quarter-end was 2.35 MSEK, up 1.7% year-over-year but down 5.0% sequentially.
Gross margin improved to 87.4% from 84.7% a year ago.
Free cash flow improved to -1.2 MSEK from -3.3 MSEK in Q1 2025, mainly due to lower investments and a more controlled cost base.
Net income was 0.2 MSEK (0.01 SEK per share) compared to -0.5 MSEK (-0.02 SEK per share) last year.
Operating expenses before capitalizations decreased to 7.8 MSEK from 10.0 MSEK, reflecting efficiency measures.
Outlook and guidance
No formal forecasts provided for the remainder of 2026.
Management expects structural changes and new contract models to support growth and improved financials for the rest of the year.
Latest events from Kontigo Care
- Recurring revenue stable, EBIT negative on one-offs, strategic shift for scalable growth.KONT
Q4 20254 Feb 2026 - Q3 EBIT margin rose to 14% despite lower sales, with new strategy and tenders boosting outlook.KONT
Q3 20256 Nov 2025 - Revenue and EBIT declined, but new partnerships and tenders set up growth for H2.KONT
Q2 202519 Aug 2025 - Record revenue and positive EBIT in Q3 2024, with ongoing product and market expansion.KONT
Q3 202413 Jun 2025 - Improved profitability and new product launches drive expansion despite public sector headwinds.KONT
Q2 202413 Jun 2025 - Revenue and recurring income fell, but strong margins and cash support European expansion.KONT
Q1 20256 Jun 2025 - Record revenue, MDR certification, and new funding drive growth and expansion plans.KONT
Q4 20245 Jun 2025